课题基金 / 基金详情

Small Molecule-Mediated Cleavage of RNA In Cells. Application to Incurable Human Genetic Disease

Small Molecule-Mediated Cleavage of RNA In Cells. Application to Incurable Human Genetic Disease
小分子介导的细胞内 RNA 切割。
批准号:
318757958
负责人:
Dr. Andrei Ursu
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Fellowships
财政年份:
2016
资助国家:
德国
项目状态:
已结题
起止时间:
2015-12-31 至 2017-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
微卫星疾病是由受影响患者基因组中存在的特定核苷酸重复引起的破坏性疾病。虽然这些重复扩张在一定长度内不是致病的,但当超过精确的阈值时,它们可能会致病。当转录时,它们启动了各种毒性机制,这些机制是20多种神经肌肉疾病的基础,包括强直性肌营养不良1型(DM1)(由CUG重复引起)和染色体9p21连锁的肌萎缩侧索硬化症(C9ALS/FTD)(由GGGGCC重复引发),目前还没有有效的治疗方法。目前的研究提案提出了两种治疗策略,旨在通过使用化学核酸酶来改善DM1和C9ALS/FTD的症状(不需要周转!)专门降解有毒RNA重复序列的物质。化学核酸酶由三个模块组成:(1)RNA结合模块,这是一个由先前被证明与重复序列相互作用的单体单元组成的多价结构;(2)连接单元;(3)RNA裂解模块,负责降解有毒的RNA扩张。我们将使用(-)-嘧啶母酸,这是一种结构复杂的抗生素博莱霉素的切割单元,以前证明它可以有效地切割核糖核酸。第一个策略将重点放在DM1上,包括使用标准的酰胺偶联反应在体外组装化学核酸酶模块。第二种方法针对C9ALS/FTD,并试图从带有炔和叠氮部分官能化的单体单元中生成纤维素中的化学核酸酶。组装过程通过原位点击化学的方式在患病细胞内进行,有毒RNA的结构作为模板催化,使单体单元紧密接近。这些方法提供了一个通用平台来处理迄今尚未有效解决的其他微卫星疾病。此外,通过化学核酸酶进行切割的方法可以应用于重复序列之外的许多其他RNA,如致癌RNA。总之,这项研究的成果将:(1)提供一种基于小分子的治疗方法来替代反义技术;(2)确定在细胞中以及在动物模型中有效靶向有毒RNA的基本规则和原则;(3)揭示促进细胞中高效和选择性切割RNA所需的小分子或小分子组件的结构特征;(4)帮助将RNA转变为可药物的靶点。
英文摘要
Microsatellite disorders are devastating diseases caused by specific nucleotide repeats present within the genome of affected patients. Whereas these repeat expansions are not pathogenic within a certain length, they can become pathogenic when exceeding a precise threshold. When transcribed, they initiate various toxic mechanisms which are the basis of more than 20 neuromuscular disorders including myotonic dystrophy type 1 (DM1) (caused by CUG repeats) and chromosome 9p21-linked amyotrophic lateral sclerosis and frontotemporal dementia (c9ALS/FTD) (triggered by GGGGCC repeats), for which at present no effective treatment exists. The current research proposal presents two therapeutic strategies meant to improve the symptoms of DM1 and c9ALS/FTD by employing chemical nucleases (without turnover!) that specifically degrade toxic RNA repeats. A chemical nuclease consists of three modules: (1) RNA binding module, a multivalent construct composed of monomeric units previously shown to interact with the repeats; (2) linker unit; (3) RNA cleavage module, responsible for the degradation of toxic RNA expansions. We will employ (-)-Pyrimidoblamic acid, the cleavage unit of a structurally complex antibiotic Bleomycin, which was previously shown to efficiently cleave ribonucleic acids. The first strategy will focus on DM1 and consists of assembling the chemical nuclease modules in vitro using standard amide coupling reactions. The second approach addresses c9ALS/FTD and attempts to generate the chemical nuclease in cellulo from monomer units functionalized with alkyne and azide moieties. The assembly process occurs within the diseased cells by means of in situ click chemistry catalyzed by the structure of the toxic RNA which acts as a template bringing the monomeric units in close proximity. These approaches offer a generalized platform to approach other microsatellite diseases that were so far not efficiently addressed. Moreover, the cleaving approach via chemical nucleases could be applied to a host of other RNAs, outside of repeats, such as cancer-causing RNAs. Altogether, the results of this research will: (1) provide a small molecule-based therapeutic alternative to antisense technology; (2) define basic rules and principles for effective targeting of toxic RNA in cellulo and potentially in animal model; (3) reveal structural features of the small molecules or small molecule assemblies required to promote efficient and selective RNA cleavage in cellulo; (4) help transform RNA into a druggable target.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
D-A类共轭聚合物晶界内部tie molecule构象调控
耦合可积系统及其molecule解的研究
  • 批准号:
    11026119
  • 项目类别:
    数学天元基金项目
  • 资助金额:
    3.0万元
  • 批准年份:
    2010
  • 负责人:
    王红艳
  • 依托单位: